A Registry of Peripartum Cardiomyopathy in Turkey
Clinical A Nation-wide Registry of Peripartum Cardiomyopathy: Clinical Status in Turkey
1 other identifier
observational
50
1 country
1
Brief Summary
Peripartum cardiomyopathy (PPCM) is a global disease with significant morbidity and mortality of young women. Its' etiology, epidemiology and treatment is not yet well described. This will be a retrospective, national, multicenter observational study, conducted in Turkey. It is expected that approximately 50 women with PPCM will be recorded.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2017
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 2, 2017
CompletedFirst Submitted
Initial submission to the registry
August 9, 2017
CompletedFirst Posted
Study publicly available on registry
December 6, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 15, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
January 15, 2018
CompletedDecember 6, 2017
December 1, 2017
7 months
August 9, 2017
December 4, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pregnancy outcome
mortality of the mother
5 months after delivery
Eligibility Criteria
Female patients with unexplained Heart Failure symptoms developed towards the end of pregnancy or in the first 6 months of postpartum period
You may qualify if:
- Patient above 18 years of age
- Unexplained Heart Failure symptoms developed towards the end of pregnancy or in the first 6 months of postpartum period
- Ejection fraction less than 45% documented with echocardiography
You may not qualify if:
- Patients with any other known cardiac pathology
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ege Universitylead
- Turkish Society of Cardiologycollaborator
Study Sites (1)
Koc University Medical School Cardiology Department
Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Dilek Ural, MD
Koc University Medical school
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof Dr
Study Record Dates
First Submitted
August 9, 2017
First Posted
December 6, 2017
Study Start
July 2, 2017
Primary Completion
January 15, 2018
Study Completion
January 15, 2018
Last Updated
December 6, 2017
Record last verified: 2017-12
Data Sharing
- IPD Sharing
- Will not share